Advertisement

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

Ann T. Farrell, Kirsten B. Goldberg and Richard Pazdur

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview